SG11202110646PA - A subunit vaccine for treatment or prevention of a respiratory tract infection - Google Patents
A subunit vaccine for treatment or prevention of a respiratory tract infectionInfo
- Publication number
- SG11202110646PA SG11202110646PA SG11202110646PA SG11202110646PA SG11202110646PA SG 11202110646P A SG11202110646P A SG 11202110646PA SG 11202110646P A SG11202110646P A SG 11202110646PA SG 11202110646P A SG11202110646P A SG 11202110646PA SG 11202110646P A SG11202110646P A SG 11202110646PA
- Authority
- SG
- Singapore
- Prior art keywords
- prevention
- treatment
- respiratory tract
- tract infection
- subunit vaccine
- Prior art date
Links
- 206010057190 Respiratory tract infections Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 229940031626 subunit vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/115—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18311—Metapneumovirus, e.g. avian pneumovirus
- C12N2760/18322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18311—Metapneumovirus, e.g. avian pneumovirus
- C12N2760/18334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19175413 | 2019-05-20 | ||
| PCT/EP2020/063973 WO2020234300A1 (en) | 2019-05-20 | 2020-05-19 | A subunit vaccine for treatment or prevention of a respiratory tract infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202110646PA true SG11202110646PA (en) | 2021-10-28 |
Family
ID=66685352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202110646PA SG11202110646PA (en) | 2019-05-20 | 2020-05-19 | A subunit vaccine for treatment or prevention of a respiratory tract infection |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US12162907B2 (es) |
| EP (1) | EP3972639A1 (es) |
| JP (1) | JP2022533318A (es) |
| KR (1) | KR20220010478A (es) |
| CN (1) | CN114127101A (es) |
| AU (1) | AU2020277661A1 (es) |
| BR (1) | BR112021021637A2 (es) |
| CA (1) | CA3138064A1 (es) |
| CL (1) | CL2021002819A1 (es) |
| CO (1) | CO2021014694A2 (es) |
| EC (1) | ECSP21079178A (es) |
| GB (1) | GB2598494B (es) |
| IL (1) | IL287099A (es) |
| MX (1) | MX2021013111A (es) |
| PE (1) | PE20220400A1 (es) |
| PH (1) | PH12021552736A1 (es) |
| SA (1) | SA521430813B1 (es) |
| SG (1) | SG11202110646PA (es) |
| WO (1) | WO2020234300A1 (es) |
| ZA (1) | ZA202106883B (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8986704B2 (en) | 2012-07-06 | 2015-03-24 | Valneva Austria Gmbh | Mutant fragments of OspA and methods and uses relating thereto |
| EP3609911B1 (en) | 2017-04-13 | 2023-07-05 | Valneva Austria GmbH | Multivalent ospa polypeptides and methods and uses relating thereto |
| PE20220400A1 (es) | 2019-05-20 | 2022-03-22 | Valneva Se | Una vacuna de subunidad para el tratamiento o la prevencion de una infeccion del tracto respiratorio |
| EP4133097A1 (en) | 2020-04-09 | 2023-02-15 | Valneva Austria GmbH | Improved methods of producing a lipidated protein |
| JP7660671B2 (ja) | 2020-10-09 | 2025-04-11 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | 融合前安定化ｈｍｐｖ ｆタンパク質 |
| KR20230107621A (ko) | 2020-11-13 | 2023-07-17 | 아이코사백스, 인크. | 메타뉴모바이러스에 대한 단백질-기반 나노입자 백신 |
| BR112023017274A2 (pt) | 2021-04-09 | 2023-11-14 | Valneva Se | Vacina contra metapneumovírus humano |
| US20240335523A1 (en) * | 2021-08-05 | 2024-10-10 | The Regents Of The University Of California | Glycoengineered Foldon Domains and Related Compositions and Methods |
| WO2023110618A1 (en) * | 2021-12-16 | 2023-06-22 | Janssen Vaccines & Prevention B.V. | Stabilized pre-fusion hmpv fusion proteins |
| TW202436325A (zh) | 2023-01-18 | 2024-09-16 | 美商輝瑞大藥廠 | 針對呼吸道疾病之疫苗 |
| US20240287544A1 (en) * | 2023-02-06 | 2024-08-29 | Cyanvac Llc | Modified piv5 vaccine vectors: methods of making and uses |
| WO2025126071A1 (en) | 2023-12-14 | 2025-06-19 | Pfizer Inc. | Rna molecules |
| CN119176858A (zh) * | 2024-11-22 | 2024-12-24 | 北京华诺泰生物医药科技有限公司 | 一种重组人偏肺病毒融合前f蛋白纯化方法 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5547871A (en) | 1993-01-25 | 1996-08-20 | American Cyanamid Company | Heterologous signal sequences for secretion of insect controlling proteins |
| ATE328890T1 (de) | 1994-07-15 | 2006-06-15 | Univ Iowa Res Found | Immunomodulatorische oligonukleotide |
| AT408721B (de) | 1999-10-01 | 2002-02-25 | Cistem Biotechnologies Gmbh | Pharmazeutische zusammensetzung enthaltend ein antigen |
| AT409085B (de) | 2000-01-28 | 2002-05-27 | Cistem Biotechnologies Gmbh | Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen |
| AT410173B (de) | 2000-06-08 | 2003-02-25 | Cistem Biotechnologies Gmbh | Antigene zusammensetzung |
| RU2293573C2 (ru) | 2000-06-08 | 2007-02-20 | Интерселл Аг | Иммуностимулирующие олигодезоксинуклеотиды |
| US20040170642A1 (en) | 2000-08-17 | 2004-09-02 | Jorg Fritiz | Vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide of a derivative thereof |
| AT410635B (de) | 2000-10-18 | 2003-06-25 | Cistem Biotechnologies Gmbh | Vakzin-zusammensetzung |
| US8715922B2 (en) * | 2001-01-19 | 2014-05-06 | ViroNovative | Virus causing respiratory tract illness in susceptible mammals |
| AU2002320762B2 (en) | 2001-05-21 | 2006-09-21 | Intercell Ag | Immunostimulatory oligodeoxynucleic molecules |
| AU2002358616A1 (en) | 2001-12-07 | 2003-06-17 | Intercell Ag | Immunostimulatory oligodeoxynucleotides |
| WO2004084938A1 (en) | 2003-03-24 | 2004-10-07 | Intercell Ag | Improved vaccines |
| EP2494987A1 (en) * | 2003-04-25 | 2012-09-05 | MedImmune Vaccines, Inc. | Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| CA2766205A1 (en) | 2009-06-24 | 2010-12-29 | Id Biomedical Corporation Of Quebec | Vaccine comprising at least two paramyxovirus f protein antigens |
| US20120315270A1 (en) | 2009-10-21 | 2012-12-13 | The United States Of America, As Represented By The | Rsv immunogens, antibodies and compositions thereof |
| CN102145167A (zh) * | 2010-02-05 | 2011-08-10 | 重庆医科大学附属儿童医院 | 重组人类偏肺病毒疫苗 |
| JP6324068B2 (ja) | 2010-05-26 | 2018-05-23 | セレクタ バイオサイエンシーズ インコーポレーテッドＳｅｌｅｃｔａ Ｂｉｏｓｃｉｅｎｃｅｓ，Ｉｎｃ． | 合成ナノキャリア混合ワクチン |
| PL3106176T3 (pl) | 2011-12-06 | 2018-03-30 | Valneva Austria Gmbh | Związki glinu do stosowania w terapeutykach i szczepionkach |
| CL2013002829A1 (es) | 2013-10-01 | 2014-04-04 | Univ Pontificia Catolica Chile | Formulacion inmunogenica que contiene bcg vivas recombinantes que expresan antigenos de metapneumovirus (hmpv) en una suspension que se prepara a partir de un liofilizado sin la necesidad de adjuvante; su uso farmaceutico; vacuna contra hmpv. |
| EP3236998A1 (en) * | 2014-12-24 | 2017-11-01 | The U.S.A. as represented by the Secretary, Department of Health and Human Services | Recombinant metapneumovirus f proteins and their use |
| PT3718565T (pt) | 2015-10-22 | 2022-07-20 | Modernatx Inc | Vacinas contra vírus respiratórios |
| EP3474893A1 (en) | 2016-06-27 | 2019-05-01 | The U.S.A. as represented by the Secretary, Department of Health and Human Services | Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigens |
| WO2019092002A1 (en) | 2017-11-07 | 2019-05-16 | Valneva Se | Pharmaceutical compositions for treatment or prevention of viral infections |
| PE20220400A1 (es) | 2019-05-20 | 2022-03-22 | Valneva Se | Una vacuna de subunidad para el tratamiento o la prevencion de una infeccion del tracto respiratorio |
| BR112023017274A2 (pt) | 2021-04-09 | 2023-11-14 | Valneva Se | Vacina contra metapneumovírus humano |
-
2020
- 2020-05-19 PE PE2021001766A patent/PE20220400A1/es unknown
- 2020-05-19 PH PH1/2021/552736A patent/PH12021552736A1/en unknown
- 2020-05-19 BR BR112021021637A patent/BR112021021637A2/pt unknown
- 2020-05-19 CA CA3138064A patent/CA3138064A1/en active Pending
- 2020-05-19 CN CN202080030901.9A patent/CN114127101A/zh active Pending
- 2020-05-19 SG SG11202110646PA patent/SG11202110646PA/en unknown
- 2020-05-19 KR KR1020217034461A patent/KR20220010478A/ko active Pending
- 2020-05-19 JP JP2021564088A patent/JP2022533318A/ja active Pending
- 2020-05-19 WO PCT/EP2020/063973 patent/WO2020234300A1/en not_active Application Discontinuation
- 2020-05-19 GB GB2114836.6A patent/GB2598494B/en active Active
- 2020-05-19 MX MX2021013111A patent/MX2021013111A/es unknown
- 2020-05-19 AU AU2020277661A patent/AU2020277661A1/en active Pending
- 2020-05-19 US US17/606,811 patent/US12162907B2/en active Active
- 2020-05-19 EP EP20726137.1A patent/EP3972639A1/en active Pending
-
2021
- 2021-09-17 ZA ZA2021/06883A patent/ZA202106883B/en unknown
- 2021-10-07 IL IL287099A patent/IL287099A/en unknown
- 2021-10-25 EC ECSENADI202179178A patent/ECSP21079178A/es unknown
- 2021-10-26 CL CL2021002819A patent/CL2021002819A1/es unknown
- 2021-10-29 CO CONC2021/0014694A patent/CO2021014694A2/es unknown
- 2021-11-10 SA SA521430813A patent/SA521430813B1/ar unknown
-
2023
- 2023-10-24 US US18/493,004 patent/US12162909B2/en active Active
-
2024
- 2024-10-31 US US18/932,700 patent/US20250171501A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20220185847A1 (en) | 2022-06-16 |
| US20250171501A1 (en) | 2025-05-29 |
| ECSP21079178A (es) | 2021-11-30 |
| WO2020234300A1 (en) | 2020-11-26 |
| US20240067681A1 (en) | 2024-02-29 |
| BR112021021637A2 (pt) | 2021-12-21 |
| CN114127101A (zh) | 2022-03-01 |
| US12162909B2 (en) | 2024-12-10 |
| GB2598494A (en) | 2022-03-02 |
| PE20220400A1 (es) | 2022-03-22 |
| PH12021552736A1 (en) | 2022-07-11 |
| CO2021014694A2 (es) | 2022-01-17 |
| AU2020277661A1 (en) | 2021-10-21 |
| KR20220010478A (ko) | 2022-01-25 |
| MX2021013111A (es) | 2021-11-17 |
| JP2022533318A (ja) | 2022-07-22 |
| ZA202106883B (en) | 2022-07-27 |
| SA521430813B1 (ar) | 2024-04-27 |
| EP3972639A1 (en) | 2022-03-30 |
| US12162907B2 (en) | 2024-12-10 |
| GB2598494B (en) | 2024-07-24 |
| CL2021002819A1 (es) | 2022-07-08 |
| CA3138064A1 (en) | 2020-11-26 |
| IL287099A (en) | 2021-12-01 |
| GB202114836D0 (en) | 2021-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2598494B (en) | A subunit vaccine for treatment or prevention of a respiratory tract infection | |
| EP3925551C0 (en) | CATHETER MOUTH DESIGNS | |
| EP3600374C0 (en) | TREATMENT OF A RESPIRATORY INFECTION | |
| SI3439578T1 (sl) | Ustnik za hlajenje ustnega tkiva pacienta med zdravljenjem s kemoterapijo | |
| IL287423A (en) | Antibodies and methods for treating influenza E infection | |
| HUE058250T2 (hu) | Gyógyszer rhinovírus-fertõzés megelõzésére vagy kezelésére | |
| IL268127A (en) | Preparations containing adrevan for oral or gastric administration and their use for treatment | |
| PT3609493T (pt) | Tratamento de uma infeção vaginal bacteriana | |
| HK40072167A (en) | A subunit vaccine for treatment or prevention of a respiratory tract infection | |
| IL272562B1 (en) | Compounds or pharmaceutically acceptable salts thereof for the treatment of mycobacterial infection | |
| GB201912059D0 (en) | Combaination therapy of a patient subgroup | |
| HUE067327T2 (hu) | Vírusos légúti fertõzések kezelése | |
| IL275150A (en) | System for hypothermia treatment of a patient | |
| IL290752A (en) | Preparations and methods for treating influenza infection a | |
| IL310974A (en) | Prevention of lower respiratory tract infection with NIRSEVIMAB | |
| ZA201907779B (en) | Fabric for preventing/treating upper respiratory tract infection | |
| IL275152A (en) | System for hypothermia treatment of a patient | |
| GB202110146D0 (en) | Treatment of respiratory conditions | |
| GB202004452D0 (en) | Respiratory treatment device | |
| AU2018900409A0 (en) | Treatment of respiratory infection (3) | |
| GB202312455D0 (en) | A vaccine for the treatment or prevention of Burkholderia species infection in a subject. | |
| GB202108866D0 (en) | Medico-surgical devices | |
| GB202108786D0 (en) | Medico-surgical devices | |
| AU2017905124A0 (en) | Treatment of respiratory infection (2) | |
| GB202101484D0 (en) | Medico-surgical devices |